Keyword: Merck


Merck Expands its Test Center for Biologics in Shanghai

28.11.2023 -

Merck has expanded its Biologics Testing Center in China with 1,500 m2 of new biosafety laboratories. The company is investing a total of €29 million in its testing...


Merck to Relocate US Healthcare Headquarters to Boston

15.11.2023 -

German chemicals, pharmaceuticals and life sciences group Merck, which operates its Healthcare business as EMD Serono in the US and Canada, announced that it plans to...


Merck Presents Fully Integrated mRNA Services

26.09.2023 -

Merck is the first CTDMO (contract testing, development, and manufacturing organization) to offer an integrated service covering all critical phases of mRNA development...


Merck Expands Cell Culture Media Production in Kansas, USA with €23 Million Investment

13.07.2023 -

Lenexa site becomes the largest production facility of dry powder cell culture media in North America.


Abcam Attracts Interest from US Life Sciences Giants

03.07.2023 -

Abcam, a biotech supplier, has garnered interest from major US life sciences companies Danaher and Agilent as it explores its potential sale. The company has also...


Germany’s Merck Expanding Reagents in China

30.06.2023 -

As part of an agreement with China’s Nantong Economic and Technological Development Area (NETDA), Germany’s Merck said it plans to spend €70 million to expand production...


FTC Intervention in Amgen-Horizon Deal Stuns Biopharma

20.06.2023 -

The US Federal Trade Commission’s lawsuit to potentially block the $27.8 merger of Amgen and Horizon Therapeutics is creating heightened concern in the international...


Merck Invests in Scottish Biosafety Unit

05.06.2023 -

Germany’s Merck is investing €35 million in biosafety testing at its Glasgow and Stirling sites in Scotland. When completed – no date has been given – the company said...